Azitra Shares Show 101% Gain in Snapshot as Company Reports Skin Data

Azitra shares showed a roughly 101% gain in an intraday snapshot Monday as the dermatology company released ex vivo skin-test results and said it would pause sales through its at-the-market program. At 12:05 p.m. ET, the shares were at $1.44, compared with a split-adjusted previous close of $0.715. The 1,900% comparison with a pre-split price near $0.07 is not comparable: Azitra’s 1-for-10 reverse split took effect at 12:01 a.m. ET Oct. 26, before split-adjusted trading began.